|Day Low/High||78.43 / 79.30|
|52 Wk Low/High||60.30 / 81.25|
It's hard to be as bullish as Ball officials when the company's multiple is way above the norm.
The most recent short interest data was recently released for the 07/15/2016 settlement date, and Ball Corp is the #153 most shorted of the S&P 500 components, based on 5.15 "days to cover." There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then divided by the average daily volume, to express the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.
Here are Monday's top research calls, including downgrades for Bristol-Myers Squibb, JPMorgan and Weyerhaeuser, and an upgrade for Merck.
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BLL, CCOI, CNNX, CVO, ETP, NUS, NYT, QSR, RYN, STM, STT, TRI, TSNU Downgrades: AM, CO, CPSH, EIGI, FSS, GDOT, IRM, TK, TTWO, TWO Initiations: TLN Read on to get TheStreet Quant Ratings' detailed report:
Jim Cramer says this merger of beverage can makers is a travesty that should have never been approved because it is going to cost consumers.
Ball's merger with Rexam creates the world's largest beverage can manufacturer, and creates newfound pricing power that could hurt the consumer.
Crude oil's two-day price rally continued to help lift markets.
Ball Corp. (BLL) reported 2016 second quarter earnings today, surpassing analysts’ estimates.
Both companies are posting big gains Thursday after reporting better-than-expected earnings, Cramer says.
Trade-Ideas LLC identified Ball (BLL) as a new lifetime high candidate
Ball (BLL) is slated to post second quarter earnings and revenue before tomorrow's market open.
Ball Aerospace and XTAR support USAF TENCAP SATCOM Demonstration
Ball (BLL) stock coverage was reinstated with an ‘equal weight’ rating and $75 price target at Barclays on Thursday.
Trade-Ideas LLC identified Ball (BLL) as a weak on high relative volume candidate
In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Ball Corp has taken over the #40 spot from CVS Health Corporation , according to ETF Channel. Below is a chart of Ball Corp versus CVS Health Corporation plotting their respective rank within the S&P 500 over time (BLL plotted in blue; CVS plotted in green): In forming the rank, the analyst opinions from the major brokerage houses were tallied, and averaged; then, the underlying components were ranked according to those averages.